Byrne C[au] - Search Results

Year	Number of Results
1830	1
1885	1
1953	1
1964	1
1967	1
1980	2
1981	2
1982	3
1983	5
1984	6
1985	5
1986	4
1987	8
1988	9
1989	3
1990	5
1991	16
1992	10
1993	5
1994	22
1995	18
1996	17
1997	25
1998	20
1999	27
2000	25
2001	27
2002	26
2003	16
2004	21
2005	36
2006	29
2007	38
2008	25
2009	37
2010	38
2011	24
2012	44
2013	46
2014	53
2015	57
2016	48
2017	58
2018	75
2019	95
2020	107
2021	91
2022	103

1

Nonalcoholic Fatty Liver Disease in Children.

Mann JP, Valenti L, Scorletti E, Byrne CD, Nobili V. Mann JP, et al. Among authors: byrne cd. Semin Liver Dis. 2018 Feb;38(1):1-13. doi: 10.1055/s-0038-1627456. Epub 2018 Feb 22. Semin Liver Dis. 2018. PMID: 29471561 Free article. Review.

2

Nonalcoholic fatty liver disease as a metabolic disease in humans: A literature review.

Cariou B, Byrne CD, Loomba R, Sanyal AJ. Cariou B, et al. Among authors: byrne cd. Diabetes Obes Metab. 2021 May;23(5):1069-1083. doi: 10.1111/dom.14322. Epub 2021 Feb 10. Diabetes Obes Metab. 2021. PMID: 33464677 Free PMC article. Review.

3

The impact of electronic health records on diagnosis.

Graber ML, Byrne C, Johnston D. Graber ML, et al. Among authors: byrne c. Diagnosis (Berl). 2017 Nov 27;4(4):211-223. doi: 10.1515/dx-2017-0012. Diagnosis (Berl). 2017. PMID: 29536944 Review.

4

Non-alcoholic fatty liver disease and childhood obesity.

Shaunak M, Byrne CD, Davis N, Afolabi P, Faust SN, Davies JH. Shaunak M, et al. Among authors: byrne cd. Arch Dis Child. 2021 Jan;106(1):3-8. doi: 10.1136/archdischild-2019-318063. Epub 2020 May 14. Arch Dis Child. 2021. PMID: 32409495 Review.

5

Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach.

Targher G, Tilg H, Byrne CD. Targher G, et al. Among authors: byrne cd. Lancet Gastroenterol Hepatol. 2021 Jul;6(7):578-588. doi: 10.1016/S2468-1253(21)00020-0. Epub 2021 May 4. Lancet Gastroenterol Hepatol. 2021. PMID: 33961787 Review.

6

MAFLD and risk of CKD.

Sun DQ, Jin Y, Wang TY, Zheng KI, Rios RS, Zhang HY, Targher G, Byrne CD, Yuan WJ, Zheng MH. Sun DQ, et al. Among authors: byrne cd. Metabolism. 2021 Feb;115:154433. doi: 10.1016/j.metabol.2020.154433. Epub 2020 Nov 16. Metabolism. 2021. PMID: 33212070

7

NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications.

Targher G, Byrne CD, Tilg H. Targher G, et al. Among authors: byrne cd. Gut. 2020 Sep;69(9):1691-1705. doi: 10.1136/gutjnl-2020-320622. Epub 2020 Apr 22. Gut. 2020. PMID: 32321858 Review.

8

The complex link between NAFLD and type 2 diabetes mellitus - mechanisms and treatments.

Targher G, Corey KE, Byrne CD, Roden M. Targher G, et al. Among authors: byrne cd. Nat Rev Gastroenterol Hepatol. 2021 Sep;18(9):599-612. doi: 10.1038/s41575-021-00448-y. Epub 2021 May 10. Nat Rev Gastroenterol Hepatol. 2021. PMID: 33972770 Review.

9

Nonalcoholic steatohepatitis: the role of peroxisome proliferator-activated receptors.

Francque S, Szabo G, Abdelmalek MF, Byrne CD, Cusi K, Dufour JF, Roden M, Sacks F, Tacke F. Francque S, et al. Among authors: byrne cd. Nat Rev Gastroenterol Hepatol. 2021 Jan;18(1):24-39. doi: 10.1038/s41575-020-00366-5. Epub 2020 Oct 22. Nat Rev Gastroenterol Hepatol. 2021. PMID: 33093663 Review.

10

Diagnosis and management of non-alcoholic fatty liver disease.

Jennison E, Patel J, Scorletti E, Byrne CD. Jennison E, et al. Among authors: byrne cd. Postgrad Med J. 2019 Jun;95(1124):314-322. doi: 10.1136/postgradmedj-2018-136316. Epub 2019 May 13. Postgrad Med J. 2019. PMID: 31085617 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results